Cite

HARVARD Citation

    Komori, M. et al. (2016). Insufficient disease inhibition by intrathecal rituximab in progressive multiple sclerosis. Annals of clinical and translational neurology. 3 (3), pp. 166-179. [Online]. 
  
Back to record